KIMS to participate in Kotak Securities 'Chasing Growth 2026' investors conference on Feb 25, 2026
Krishna Institute of Medical Sciences Limited (KIMS) will attend the 'Chasing Growth 2026' investors conference hosted by Kotak Securities in Mumbai on February 25, 2026. This is a group meeting with investors, and no price-sensitive information will be disclosed.
The announcement is a standard disclosure of an upcoming investor meeting, which is a routine activity for listed companies. It does not provide any new material information that would significantly impact the company's stock or operations.
The announcement is a routine intimation about an upcoming investor meeting and does not contain any new financial results or strategic information that would impact the sentiment.
Krishna Institute of Medical Sciences Limited (KIMS) has announced its participation in the 'Chasing Growth 2026' investors conference, organized by Kotak Securities. The meeting is scheduled to take place in Mumbai, India, on February 25, 2026.
This event is categorized as a Group Meeting with investors. The schedule is subject to change based on any exigencies. KIMS has stated that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.
This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.